Mirtazapine Tablet
Product Images NDC 63629-2368

2 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 63629-2368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)
Chemical structure diagram of Mirtazapine, showing its molecular framework with nitrogen-containing rings and a methyl group attached to a nitrogen atom.*
FDA Label Image

Label (Lbl636292368)

Label (Lbl636292368)
Label for Mirtazapine Tablets, USP 30 mg oral tablets by Bryant Ranch Prepack. The label includes the NDC 63629-2368-1, a barcode, and states the package contains 30 tablets. Instructions include storage at 20° to 25°C and dispensing in a child-resistant container. The Bryant Ranch Prepack logo is visible at the bottom right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.